2'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF
Halogenated analogs of 5-aza-2'-deoxycytidine, such as halogenated analogs of 5-aza-4'-thio-2'-deoxycytidine (5-aza-T-dCyd) are described. Pharmaceutical compositions including a halogenated analog and methods of using the halogenated analogs to inhibit neoplasia are described. In som...
Gespeichert in:
| Hauptverfasser: | , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | LOPEZ, Omar Diego MORRIS, Joel WISHKA, Donn G |
| description | Halogenated analogs of 5-aza-2'-deoxycytidine, such as halogenated analogs of 5-aza-4'-thio-2'-deoxycytidine (5-aza-T-dCyd) are described. Pharmaceutical compositions including a halogenated analog and methods of using the halogenated analogs to inhibit neoplasia are described. In some examples, the halogenated analogs have a structure according to formula Ia, or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof:
L'invention concerne des analogues halogénés de 5-aza -2'-désoxycytidine, tels que des analogues halogénés de 5-aza-4'-thio-2'-désoxycytidine (5-aza-T-dCyd). L'invention concerne également des compositions pharmaceutiques comprenant un analogue halogéné et des procédés d'utilisation des analogues halogénés pour inhiber une néoplasie. L'invention concerne, selon certains exemples, des analogues halogénés ayant la structure de formule Ia, ou un stéréoisomère, un tautomère, ou un sel pharmaceutiquement acceptable de ceux-ci. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_WO2020068657A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>WO2020068657A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_WO2020068657A13</originalsourceid><addsrcrecordid>eNrjZHA1Utf1cPTxd3f1cwxxddE1UdcN8fD01wUKu7j6R0Tqmuo6Rjk6R4Z4unj6uSo4-oHUBgNpF4XQYFeFEA_XIFd_Nx4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgZGBgZmFmau5oaEycKgCpGCwB</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>2'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF</title><source>esp@cenet</source><creator>LOPEZ, Omar Diego ; MORRIS, Joel ; WISHKA, Donn G</creator><creatorcontrib>LOPEZ, Omar Diego ; MORRIS, Joel ; WISHKA, Donn G</creatorcontrib><description>Halogenated analogs of 5-aza-2'-deoxycytidine, such as halogenated analogs of 5-aza-4'-thio-2'-deoxycytidine (5-aza-T-dCyd) are described. Pharmaceutical compositions including a halogenated analog and methods of using the halogenated analogs to inhibit neoplasia are described. In some examples, the halogenated analogs have a structure according to formula Ia, or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof:
L'invention concerne des analogues halogénés de 5-aza -2'-désoxycytidine, tels que des analogues halogénés de 5-aza-4'-thio-2'-désoxycytidine (5-aza-T-dCyd). L'invention concerne également des compositions pharmaceutiques comprenant un analogue halogéné et des procédés d'utilisation des analogues halogénés pour inhiber une néoplasie. L'invention concerne, selon certains exemples, des analogues halogénés ayant la structure de formule Ia, ou un stéréoisomère, un tautomère, ou un sel pharmaceutiquement acceptable de ceux-ci.</description><language>eng ; fre</language><subject>CHEMISTRY ; DERIVATIVES THEREOF ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; NUCLEIC ACIDS ; NUCLEOSIDES ; NUCLEOTIDES ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SUGARS</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200402&DB=EPODOC&CC=WO&NR=2020068657A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20200402&DB=EPODOC&CC=WO&NR=2020068657A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>LOPEZ, Omar Diego</creatorcontrib><creatorcontrib>MORRIS, Joel</creatorcontrib><creatorcontrib>WISHKA, Donn G</creatorcontrib><title>2'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF</title><description>Halogenated analogs of 5-aza-2'-deoxycytidine, such as halogenated analogs of 5-aza-4'-thio-2'-deoxycytidine (5-aza-T-dCyd) are described. Pharmaceutical compositions including a halogenated analog and methods of using the halogenated analogs to inhibit neoplasia are described. In some examples, the halogenated analogs have a structure according to formula Ia, or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof:
L'invention concerne des analogues halogénés de 5-aza -2'-désoxycytidine, tels que des analogues halogénés de 5-aza-4'-thio-2'-désoxycytidine (5-aza-T-dCyd). L'invention concerne également des compositions pharmaceutiques comprenant un analogue halogéné et des procédés d'utilisation des analogues halogénés pour inhiber une néoplasie. L'invention concerne, selon certains exemples, des analogues halogénés ayant la structure de formule Ia, ou un stéréoisomère, un tautomère, ou un sel pharmaceutiquement acceptable de ceux-ci.</description><subject>CHEMISTRY</subject><subject>DERIVATIVES THEREOF</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>NUCLEIC ACIDS</subject><subject>NUCLEOSIDES</subject><subject>NUCLEOTIDES</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SUGARS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZHA1Utf1cPTxd3f1cwxxddE1UdcN8fD01wUKu7j6R0Tqmuo6Rjk6R4Z4unj6uSo4-oHUBgNpF4XQYFeFEA_XIFd_Nx4G1rTEnOJUXijNzaDs5hri7KGbWpAfn1pckJicmpdaEh_ub2RgZGBgZmFmau5oaEycKgCpGCwB</recordid><startdate>20200402</startdate><enddate>20200402</enddate><creator>LOPEZ, Omar Diego</creator><creator>MORRIS, Joel</creator><creator>WISHKA, Donn G</creator><scope>EVB</scope></search><sort><creationdate>20200402</creationdate><title>2'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF</title><author>LOPEZ, Omar Diego ; MORRIS, Joel ; WISHKA, Donn G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_WO2020068657A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre</language><creationdate>2020</creationdate><topic>CHEMISTRY</topic><topic>DERIVATIVES THEREOF</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>NUCLEIC ACIDS</topic><topic>NUCLEOSIDES</topic><topic>NUCLEOTIDES</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SUGARS</topic><toplevel>online_resources</toplevel><creatorcontrib>LOPEZ, Omar Diego</creatorcontrib><creatorcontrib>MORRIS, Joel</creatorcontrib><creatorcontrib>WISHKA, Donn G</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>LOPEZ, Omar Diego</au><au>MORRIS, Joel</au><au>WISHKA, Donn G</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>2'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF</title><date>2020-04-02</date><risdate>2020</risdate><abstract>Halogenated analogs of 5-aza-2'-deoxycytidine, such as halogenated analogs of 5-aza-4'-thio-2'-deoxycytidine (5-aza-T-dCyd) are described. Pharmaceutical compositions including a halogenated analog and methods of using the halogenated analogs to inhibit neoplasia are described. In some examples, the halogenated analogs have a structure according to formula Ia, or a stereoisomer, tautomer, or pharmaceutically acceptable salt thereof:
L'invention concerne des analogues halogénés de 5-aza -2'-désoxycytidine, tels que des analogues halogénés de 5-aza-4'-thio-2'-désoxycytidine (5-aza-T-dCyd). L'invention concerne également des compositions pharmaceutiques comprenant un analogue halogéné et des procédés d'utilisation des analogues halogénés pour inhiber une néoplasie. L'invention concerne, selon certains exemples, des analogues halogénés ayant la structure de formule Ia, ou un stéréoisomère, un tautomère, ou un sel pharmaceutiquement acceptable de ceux-ci.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre |
| recordid | cdi_epo_espacenet_WO2020068657A1 |
| source | esp@cenet |
| subjects | CHEMISTRY DERIVATIVES THEREOF HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY NUCLEIC ACIDS NUCLEOSIDES NUCLEOTIDES ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SUGARS |
| title | 2'-HALOGENATED-4'-THIO-2'-DEOXY-5-AZACYTIDINE ANALOGS AND USE THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-06T00%3A20%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=LOPEZ,%20Omar%20Diego&rft.date=2020-04-02&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EWO2020068657A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |